2019 Opioids Market Share, Size, Growth Rate by Market Current S

2019 Opioids Market Share, Size, Growth Rate by Market Current Strategy, Top Most Players, and Regional Segmentation by Forecast to 2024

Posted:

Report Titled:Opioids Market - Growth, Trends, and Forecast (2019 - 2024)

Opioids Marketreport consists of an extensive primary research, as well as an in-depth analysis of the qualitative and quantitative aspects by various industry specialists and professionals, to gain a deeper insight of the market and the overall landscape. Opioids market also shows information of Product awareness, adept workforce, technological advancements, raw material affluence, favorable environment, and rapidly growing product demand are some factors that persistently boost the growth of the Opioids market.

Get Sample PDF of Opioids Market Report @https://www.industryresearch.co/enquiry/request-sample/14244772

Scope of the Report:

  • According to the report, opioids are a class of drugs that act on the nervous system to reduce pain. They are primarily used for pain relief and for anesthesia. The scope of this report is limited to products tracked in the opioid market segmentation.

Major Key Players:

  • Allergan Plc
  • Mallinckrodt LLC
  • Purdue Pharma LP
  • Rhodes Technologies LP
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical
  • Vertice Pharma LLC
  • Johnson and Johnson
  • INSYS Therapeutics
  • Hikma Pharmaceuticals PLC
  • Endo Pharmaceuticals Inc.
  • Egalet Corporation
  • Amneal Pharmaceuticals

Market Overview:

  • - Opioids are considered as some of the most effective drugs for the management of pain. Moreover, their use in the management of severe pain and chronic pain, which are associated with advanced medical illness, is considered to be standard practice in most parts of the world. Due to an increase in the incidence of medical ailments, the market studied is expected to grow over the forecast period.
  • - The rising occurrence of orthopedic disorders, such as arthritis, elbow pain, fibromyalgia, and osteoporosis, and the associated chronic pain, is the primary factor responsible for the growth of the opioids market. Opioids play a vital role in acute post-operative settings to provide adequate analgesia. As per the Center for Disease Control and Prevention, over 30 million patients are affected by osteoarthritis each year in the United States. There is an increasing rate of osteoarthritis in the United Kingdom. According to the Arthritis UK in 2016, approximately one in five adults over 45 years in England had osteoarthritis in knee and one in nine adults had osteoarthritis in hip, which amount to around 8.5 million people suffering from the disease. In addition, the International Osteoporosis Foundation states that osteoporosis is considered as one of the most serious public health concerns among women, affecting more than 30% of the population each year in the United States and Europe and leading to multiple fractures.
  • - According to the Office of National Drug Control Policy, in 2016, opioid painkillers were the most-commonly prescribed medication in the United States. Additionally, according to a recent study published in the Archives of Internal Medicine in 2017, it was estimated that 15% to 20% of physician visits in the United States involve an opioid prescription.
  • - Therefore, opioid therapy is the mainstay of orthopedic treatment of patients with moderate to severe pain, and this drives the growth of the opioid market.

Inquire Before Purchase Opioids Market Report @https://www.industryresearch.co/enquiry/pre-order-enquiry/14244772

Key Market Trends:

Strong Agonists are Expected to Hold the Largest Market Share in the Receptor Binding Segment

In the receptor binding segment of the opioids market, the strong agonist category is expected to have the largest market size. This segment is expected to witness a CAGR of 5.02% in the forecast period. An agonist is a drug that triggers certain receptors in the brain. Methadone (strong) agonist therapy is an effective treatment for addiction to opioid drugs (such as heroin). Strong agonist opioids activate opioid receptors, and after binding tightly, undergo significant conformational changes. Strong agonists include codeine, fentanyl, heroin, hydrocodone, methadone, morphine, and oxycodone. As per the US Department of Health and Human Services and National Institutes of Health, in 2015, 25.4 million Americans adults experienced pain daily. This statistic indicates the importance of pain management and impacts the opioid market positively.

North America Dominates the Market and is Expected to Continue to Dominate in the Forecast Period

North America currently dominates the market for opioids and is expected to continue its strong hold for a few more years. Codeine and morphine are the most commonly prescribed opioids for cancer patients to relieve pain. However, illegal use of fentanyl to relieve pain is rising across the United States. Recently, in 2018, despite the escalating trade war between the United States and China, medical and law enforcement officials and politicians tried to stop illegally mailed fentanyl from China to the United States. Some of the major companies in the United States market include Teva, Janssen, Insys, and Mylan. However, some of these companies have been involved in legal actions instituted against them for persuading doctors to influence sales of opioids to boost the market.

In the past two years, initiatives and campaigns have been initiated under the Centers for Disease Control and Prevention and Federal government to fight the opioid epidemic. Due to these actions, growth of the studied market is expected to steadily slow down over the forecast period.

Competitive Landscape:

Most of the companies present in the market are efficient at the technological front, but require significant support for enhancing their services and expanding their businesses. Thus, mergers and acquisitions offer significant opportunities to gain the attention of a large number of providers across developed regions.

PurchaseOpioids MarketReport of $ 4250 (SUL) @https://www.industryresearch.co/purchase/14244772

Opioids Market Covers Following Points in TOC:

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Orthopedic Diseases and Chronic Pain
4.2.2 Inclination toward Extended Release Formulations from Immediate Release of Opioids
4.2.3 Rising Focus on Abuse-deterrent Formulation (ADF) by Generic Manufacturers
4.2.4 Growing Palliative Care Facilities
4.3 Market Restraints
4.3.1 Advent and Legalization of Cannabis as an Alternative to Opioids
4.3.2 Prescription Drug Abuse
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 Product Type
5.1.1 Codeine
5.1.2 Fentanyl
5.1.3 Morphine
5.1.4 Meperidine
5.1.5 Methadone
5.1.6 Other Product Types
5.2 Receptor Binding
5.2.1 Strong Agonist
5.2.2 Mild to Moderate Agonist
5.3 Application
5.3.1 Pain Management
5.3.1.1 Cancer Pain
5.3.1.2 Neuropathic Pain
5.3.1.3 Osteoarthritis Pain
5.3.1.4 Other Pain Managements
5.3.2 Cold and Cough
5.3.3 Diarrhoea
5.3.4 Other Applications
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergan Plc
6.1.2 Mallinckrodt LLC
6.1.3 Purdue Pharma LP
6.1.4 Rhodes Technologies LP
6.1.5 Sun Pharmaceutical Industries Ltd
6.1.6 Teva Pharmaceutical
6.1.7 Vertice Pharma LLC
6.1.8 Johnson and Johnson
6.1.9 INSYS Therapeutics
6.1.10 Hikma Pharmaceuticals PLC
6.1.11 Endo Pharmaceuticals Inc.
6.1.12 Egalet Corporation
6.1.13 Amneal Pharmaceuticals

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

About Industry Research:

Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

Contact Us:

Name: Ajay More

Organization: Industry Research

Phone: +44 20 3239 8187 / +14242530807

Email: sales@industryresearch.co

Our latest Report:Photonic Integrated Circuit Market 2019-2024 | Product Demand Status, Development, Market Drivers, Restraints, and Opportunities, Forecast to 2024

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit 2019 Opioids Market Share, Size, Growth Rate by Market Current Strategy, Top Most Players, and Regional Segmentation by Forecast to 2024

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com

Powered by Frankly